{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:13:46Z","timestamp":1784157226796,"version":"3.55.0"},"reference-count":31,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Adrenocortical carcinoma (ACC) is a rare malignancy arising from the adrenal cortex. While ACC can be associated with adrenal hormone excess syndromes, classic paraneoplastic syndromes are rarely seen. Stauffer syndrome, a paraneoplastic phenomenon characterized by reversible cholestasis in the absence of liver metastases, has been described with renal carcinoma and other malignancies but has not been previously reported in ACC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case Presentation<\/jats:title>\n                  <jats:p>A 38-year-old man presented with emesis, painless jaundice, pruritus, and weight loss. Laboratory evaluation demonstrated elevated total bilirubin of 8.7 mg\/dL (N\u2005&amp;lt;\u20051.3 mg\/dL). Computed tomography revealed a 20.4-cm left adrenal mass without evidence of liver metastases. The patient\u2019s condition deteriorated rapidly with progressive renal failure and worsening hyperbilirubinemia. The patient underwent left adrenalectomy, nephrectomy, ureterolysis, and wedge liver biopsy. Histopathology showed necrotic ACC with tumor invasion into the adrenal capsule, no lymphovascular invasion, uninvolved margins, and Ki-67 of 40%. Kidney parenchyma exhibited diffuse pigment casts. The liver specimen contained diffuse bile deposits and minimal chronic inflammation in the portal tracts. He tested positive for the pathogenic variant of folliculin (FLCN) gene consistent with Birt-Hogg-Dube syndrome. Renal function recovered after surgery, and bilirubin level normalized after several weeks. Based on clinical presentation and absence of other etiologies, reversible cholestatic jaundice was attributed to Stauffer syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the first report of a unique presentation of paraneoplastic-related hyperbilirubinemia in the setting of ACC. While extremely rare, Stauffer syndrome should still be considered in differential diagnosis in patients with ACC with liver dysfunction and jaundice without evidence of liver metastases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvac101","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T12:20:53Z","timestamp":1656505253000},"source":"Crossref","is-referenced-by-count":2,"title":["Severe Cholestatic Jaundice (Stauffer Syndrome) as a Rare Paraneoplastic Manifestation in Adrenocortical Carcinoma"],"prefix":"10.1210","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-2285","authenticated-orcid":false,"given":"Natia","family":"Murvelashvili","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, UT Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio M","family":"Polanco","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, UT Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Khorsand","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Management, UT Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A","family":"Marrero","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Pennsylvania , Philadelphia, Pennsylvania 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Pathology, UT Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4251-5737","authenticated-orcid":false,"given":"Sasan","family":"Mirfakhraee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, UT Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2262-0011","authenticated-orcid":false,"given":"Tobias","family":"Else","sequence":"additional","affiliation":[{"name":"Division Division of Metabolism, Endocrinology and Diabetes, University of Michigan , Ann Arbor, Michigan 48109 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhammed Amir","family":"Habra","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Cole","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, UT Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-3885","authenticated-orcid":false,"given":"Oksana","family":"Hamidi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, UT Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"12","key":"2022070713172236500_CIT0001","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022070713172236500_CIT0002","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer."},{"issue":"4","key":"2022070713172236500_CIT0003","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","article-title":"Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer","volume":"65","author":"Berruti","year":"2014","journal-title":"Eur Urol."},{"issue":"2","key":"2022070713172236500_CIT0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","article-title":"Clinical management of adrenocortical carcinoma","volume":"23","author":"Fassnacht","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"11","key":"2022070713172236500_CIT0005","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"2022070713172236500_CIT0006","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"17","key":"2022070713172236500_CIT0007","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N Engl J Med."},{"issue":"1","key":"2022070713172236500_CIT0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol."},{"issue":"12","key":"2022070713172236500_CIT0009","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrurol.2010.186","article-title":"Paraneoplastic syndromes in prostate cancer","volume":"7","author":"Hong","year":"2010","journal-title":"Nat Rev Urol."},{"issue":"4","key":"2022070713172236500_CIT0010","first-page":"216","article-title":"Paraneoplastic manifestations of renal cell carcinoma","volume":"14","author":"Gold","year":"1996","journal-title":"Semin Urol Oncol"},{"key":"2022070713172236500_CIT0011","doi-asserted-by":"crossref","first-page":"bcr0720092100","DOI":"10.1136\/bcr.07.2009.2100","article-title":"Cushing\u2019s syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma","volume":"2010","author":"Ishikura","year":"2010","journal-title":"BMJ Case Rep."},{"key":"2022070713172236500_CIT0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/5731417","article-title":"Nonislet cell tumor hypoglycemia in a patient with adrenal cortical carcinoma","volume":"2016","author":"Kim","year":"2016","journal-title":"Case Rep Endocrinol"},{"issue":"2","key":"2022070713172236500_CIT0013","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.47.119","article-title":"A case of renin-producing adrenocortical cancer","volume":"47","author":"Yamanaka","year":"2000","journal-title":"Endocr J."},{"issue":"8","key":"2022070713172236500_CIT0014","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1210\/jcem.86.8.7780","article-title":"Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome","volume":"86","author":"Schteingart","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022070713172236500_CIT0015","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-5347(17)57519-9","article-title":"Non-metastatic hepatic dysfunction associated with renal carcinoma","volume":"119","author":"Boxer","year":"1978","journal-title":"J Urol."},{"issue":"10","key":"2022070713172236500_CIT0016","first-page":"e6032","article-title":"Stauffer syndrome: a comprehensive review of the icteric variant of the syndrome","volume":"11","author":"Sharma","year":"2019","journal-title":"Cureus."},{"issue":"7","key":"2022070713172236500_CIT0017","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.urolonc.2018.01.019","article-title":"Stauffer\u2019s syndrome: a comprehensive review and proposed updated diagnostic criteria","volume":"36","author":"Fontes-Sousa","year":"2018","journal-title":"Urol Oncol."},{"issue":"10","key":"2022070713172236500_CIT0018","first-page":"35","article-title":"The great imposter: a confusing case of a rare renal cell carcinoma","volume":"103","author":"Song","year":"2020","journal-title":"R I Med J (2013)."},{"issue":"2","key":"2022070713172236500_CIT0019","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1159\/000508039","article-title":"A rare presentation of Stauffer\u2019s syndrome associated with renal cell carcinoma","volume":"13","author":"Tanous","year":"2020","journal-title":"Case Rep Oncol."},{"issue":"5","key":"2022070713172236500_CIT0020","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(89)91706-X","article-title":"Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma","volume":"97","author":"Watterson","year":"1989","journal-title":"Gastroenterology."},{"issue":"5","key":"2022070713172236500_CIT0021","first-page":"e1230","article-title":"Stauffer\u2019s syndrome in pancreatic cancer: first case report","volume":"9","author":"Harris","year":"2017","journal-title":"Cureus."},{"issue":"4","key":"2022070713172236500_CIT0022","first-page":"609","article-title":"Reversible intrahepatic cholestasis in metastatic prostate cancer: an uncommon paraneoplastic syndrome","volume":"8","author":"Bhangoo","year":"2018","journal-title":"Mol Clin Oncol."},{"issue":"1","key":"2022070713172236500_CIT0023","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5152\/tud.2018.52059","article-title":"Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature","volume":"45","author":"G\u00f6k\u00e7en","year":"2019","journal-title":"Turk J Urol."},{"key":"2022070713172236500_CIT0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9745301","article-title":"Stauffer\u2019s syndrome in patient with metastatic prostate cancer","volume":"2019","author":"Roma\u0161ovs","year":"2019","journal-title":"Case Rep Urol."},{"key":"2022070713172236500_CIT0025","article-title":"Jaundice.","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"John","year":"2018","edition":"20"},{"issue":"4","key":"2022070713172236500_CIT0026","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-5347(17)37505-5","article-title":"Inhibitory effects of suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction","volume":"147","author":"Chang","year":"1992","journal-title":"J Urol."},{"issue":"3","key":"2022070713172236500_CIT0027","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-5347(01)63709-1","article-title":"Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival","volume":"159","author":"Walther","year":"1998","journal-title":"J Urol."},{"issue":"8","key":"2022070713172236500_CIT0028","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1172\/JCI126022","article-title":"IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion","volume":"129","author":"Chan","year":"2019","journal-title":"J Clin Invest."},{"key":"2022070713172236500_CIT0029","doi-asserted-by":"crossref","first-page":"200042","DOI":"10.1183\/16000617.0042-2020","article-title":"Birt-Hogg-Dub\u00e9 syndrome","volume":"29","author":"Daccord","year":"2020","journal-title":"Eur Respir Rev."},{"issue":"6","key":"2022070713172236500_CIT0030","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/cen.12292","article-title":"An oncocytic adrenal tumour in a patient with Birt-Hogg-Dub\u00e9 syndrome","volume":"80","author":"Raymond","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022070713172236500_CIT0031","first-page":"1","article-title":"Oncocytoma of the adrenal gland in Birt-Hogg-Dube syndrome","volume":"2018","author":"Ramsingh","year":"2018","journal-title":"BMJ Case Rep."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvac101\/44281433\/bvac101.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/8\/bvac101\/44543373\/bvac101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/8\/bvac101\/44543373\/bvac101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:18:42Z","timestamp":1657199922000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvac101\/6619513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvac101","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,6,29]]},"article-number":"bvac101"}}